These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35609529)

  • 21. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial.
    Sedhain A; Hada R; Agrawal RK; Bhattarai GR; Baral A
    BMC Nephrol; 2018 Jul; 19(1):175. PubMed ID: 29996800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis.
    Zhou T; Lin S; Yang S; Lin W
    Drug Des Devel Ther; 2019; 13():857-869. PubMed ID: 30880918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: A systematic review and meta-analysis.
    Jiang YP; Zhao XX; Chen RR; Xu ZH; Wen CP; Yu J
    Medicine (Baltimore); 2020 Sep; 99(38):e22328. PubMed ID: 32957400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments for Lupus Nephritis: A Systematic Review and Network Metaanalysis.
    Singh JA; Hossain A; Kotb A; Oliveira A; Mudano AS; Grossman J; Winthrop K; Wells GA
    J Rheumatol; 2016 Oct; 43(10):1801-1815. PubMed ID: 27585688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients.
    Rosli FZ; Shaharir SS; Abdul Gafor AH; Mohd R; Aizuddin AN; Osman S
    Lupus; 2022 Aug; 31(9):1138-1146. PubMed ID: 35608373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of calcineurin inhibitors in the induction and maintenance treatment of lupus nephritis: a systematic review and meta-analysis.
    Zhang X; Ji L; Yang L; Tang X; Qin W
    Int Urol Nephrol; 2016 May; 48(5):731-43. PubMed ID: 26781720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moderator's view: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Kronbichler A; Neumann I; Mayer G
    Nephrol Dial Transplant; 2016 Oct; 31(10):1572-6. PubMed ID: 27591329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Con: Cyclophosphamide for the treatment of lupus nephritis.
    Mok CC
    Nephrol Dial Transplant; 2016 Jul; 31(7):1053-7. PubMed ID: 27190358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil vs. cyclophosphamide-based induction regimens for lupus nephritis: Outcomes at a tertiary care centre in Lahore, Pakistan.
    Saeed MA; Khan A; Naeem F; Ahmad NM
    J Pak Med Assoc; 2024 May; 74(5):868-873. PubMed ID: 38783432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
    Gul H; Mushtaq MS; Salim B; Samreen S; Nasim A; Khan M
    J Ayub Med Coll Abbottabad; 2020; 32(4):454-458. PubMed ID: 33225643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis.
    Kawazoe M; Nanki T
    Lupus; 2024 Apr; 33(4):319-327. PubMed ID: 38232223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
    Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W
    J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and adverse events of mycophenolate mofetil versus cyclophosphamide for induction therapy of lupus nephritis: systematic review and meta-analysis.
    Kamanamool N; McEvoy M; Attia J; Ingsathit A; Ngamjanyaporn P; Thakkinstian A
    Medicine (Baltimore); 2010 Jul; 89(4):227-235. PubMed ID: 20616662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy and safety of mycophenolate mofetil versus cyclophosphamide in patients with active antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of randomized trials.
    Song GG; Lee YH
    Z Rheumatol; 2021 Jun; 80(5):425-431. PubMed ID: 32337635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide.
    Chbihi M; Eveillard LA; Riller Q; Brousse R; Berthaud R; Quartier P; Salomon R; Charbit M; Avramescu M; Biebuyck N; Dehoux L; Garcelon N; Duong-Van-Huyen JP; Bader-Meunier B; Boyer O
    J Nephrol; 2023 Apr; 36(3):829-839. PubMed ID: 36208405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D; Rodrigues M; da Silva JAP; Inês L
    Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
    Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
    Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.